clinical trial · NCT06953869
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Insomnia DisorderTasimelteon Oral SuspensionPlacebo
brief summary
This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female pediatric participants with insomnia disorder.
started
Apr 21, 2025
primary completion
Nov 1, 2027
completion
Jan 1, 2028
last updated
May 1, 2025
official title
A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol